Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold (...)
Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. While Jefferies downgraded the target to Rs 4,460 citing weak margins, Nomura maintained a ‘Buy’ with a Rs 5,430 target. The company expects high single-digit (...)
Site référencé: The Economic Times
The Economic Times
Bank Nifty crosses 56,000 to hit record high as RBI rate decision looms
3/06/2025
What we can learn about Xi's rule by studying his father's life
3/06/2025
Pick undervalued, high-quality stocks : Sonam Srivastava's 2025 playbook
3/06/2025
Vodafone Idea shares slide 4% as telco engages with govt for AGR relief post SC plea dismissal
3/06/2025
ETMarkets Smart Talk : India’s market cap could hit $10 trillion by 2030, says ArthAlpha’s Rohit Beri
3/06/2025
Six months after deposing Assad, Syria faces security, economic challenges
3/06/2025
